Baricitinib demonstrates sustained long-term efficacy in patients with moderate-to-severe atopic dermatitis, according to a study published online May 12 in […]
Results from phase 3 trial show baricitinib reduces deaths from COVID-19
The latest results from a study to assess the efficacy of the arthritis drug, baricitinib, in treating COVID-19 patients have […]